|
A.S. Ametov (1), N.A. Chernikova (1), T.Yu. Demidova (1), P.K. Nazhmutdinova (2)
GLYCEMIC VARIABILITY AS A THERAPEUTIC TARGET IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
8-13 |
|
L.A. Ruyatkina (1), D.S. Ruyatkin (1), S.A. Zemlyanukhina (2)
DIABETIC ANGIOPATHY «PAINFUL» POINTS: FOCUS ON HYPERTRIGLYCERIDEMIA AND FENOFIBRATE POTENTIAL
|
14-21 |
|
A.V. Pashentseva, A.F. Verbovoy, O.V. Kosareva, L.A. Sharonova
MODERN POSSIBILITIES OF OSTEOPOROSIS TREATMENT
|
22-29 |
|
V.A. Golovacheva, V.A. Parfenov
MODERN TACTICS OF MANAGEMENT OF PATIENTS WITH DIABETIC POLYNEUROPATHY
|
30-37 |
|
M.B. Antsiferov
APPLICATION OF SAXAGLIPTIN AND ITS COMBINATION WITH METFORMIN IN THE THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS
|
38-44 |
|
D.V. Kurkin, E.V. Volotova, D.A. Bakulin, E.M. Lomkina, I.N. Tyurenkov
INCRETIN SYSTEM AS PROMISING PHARMACOLOGICAL TARGET FOR HYPOGLYCEMIC THERAPY
|
45-50 |
|
E.V. Biryukova
EMPAGLIFLOZIN: ENHANCEMENT OF POTENTIALS OF THE TREATMENT OF TYPE 2 DIABETES MELLITUS
|
51-61 |
|
O.L. Badalyan, A.A. Savenkov
PATHOGENETIC THERAPY OF DIABETIC POLYNEUROPATHY
|
62-65 |
|
O.M. Koteshkova, L.P. Molina
EFFICIENCY OF MULTICOMPONENT THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (CLINICAL CASE)
|
66-70 |
|
M.F. Kalashnikova, A.V. Zilov, D.R. Yazykova, N.V. Likhodey, V.V. Fadeev
POTENTIALS FOR THE IMPROVEMENT OF TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS USING HUMAN ULTRA-LONG INSULIN ANALOGUE DEGLUDEC IN OUTPATIENT SETTINGS
|
71-78 |
|
D.V. Stafeev, A.Yu. Kochish, S.N. Ivanov
EVALUATION OF THE EFFICACY OF THERAPY OF OSTEOPOROSIS IN PATIENTS WITH EXTRA-ARTICULAR FRACTURES OF THE PROXIMAL FEMUR
|
79-85 |
|
A.S. Adamchik, D.I. Panchenko
INCREASED THYROID-STIMULATING HORMONE LEVEL AS A MARKER OF PROGRESSION OF HEART FAILURE IN CARDIAC PATIENTS
|
86-88 |
|
A.V. Tolkushin
OVERVIEW OF PHARMACOECONOMIC STUDIES OF INSULIN PUMP THERAPY IN DIABETES MELLITUS
|
89-95 |
Русский
